glp 1 vision issues GLP-1 Medications and NAION: What Patients Should Know About Sudden Loss GLP 1 Blindness Risk |

Dpp-iv inhibitory potential of naringin: An in silico, in vitro and in vivo study

However, another study with similar design did not see any association between GLP-1RA exposure and changes in new-onset depression or self-harm over 16,910 patients with diabetes over approximately 1 year of follow-up 201

While a randomized trial is still needed, the fact that many patients with IIH already qualify for GLP-1s due to diabetes or obesity means clinicians may reasonably view these drugs as a valuable option, especially compared to older medications with more side effects

(2009) Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiology